Natalizumab and the development of extensive brain lesions in neuromyelitis optica
- 30 May 2013
- journal article
- letter
- Published by Springer Science and Business Media LLC in Zeitschrift für Neurologie
- Vol. 260 (7), 1919-1921
- https://doi.org/10.1007/s00415-013-6965-4
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Distinction of seropositive NMO spectrum disorder and MS brain lesion distributionNeurology, 2013
- Effect of Natalizumab on Circulating CD4+ T-Cells in Multiple SclerosisPLOS ONE, 2012
- Does natalizumab therapy worsen neuromyelitis optica?Neurology, 2012
- Conventional brain MRI in neuromyelitis opticaEuropean Journal of Neurology, 2011
- Massive astrocyte destruction in neuromyelitis optica despite natalizumab therapyMultiple Sclerosis Journal, 2011
- Brain abnormalities in neuromyelitis opticaJournal of the Neurological Sciences, 2011
- Natalizumab treatment is associated with peripheral sequestration of proinflammatory T cellsNeurology, 2009
- Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disordersNeurology, 2009
- Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) studyThe Lancet Neurology, 2009
- Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosisNeurology, 2008